Tetraphase Pharmaceuticals buy melinda
Start price
25.04.17
/
50%
€148.11
Target price
25.10.17
€8.12
Performance (%)
-24.85%
End price
25.10.17
€111.31
Summary
This prediction ended on 25.10.17 with a price of €111.31. The price of Tetraphase Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tetraphase Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
Comments by melinda for this prediction
In the thread Tetraphase Pharmaceuticals diskutieren
Infektionen
Tetraphase Pharmaceuticals, Inc. engagiert in der Entwicklung und Produktion neuer Antibiotika für schwere bakterielle infections.It und die Prognose eines Produktkandidaten entwickelt, eravacycline
(Laufzeit überschritten)
Stopped prediction by melinda for Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€0.22
03.03.20
03.03.20
€0.50
04.11.21
04.11.21
-
05.11.21
05.11.21
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€14.08
25.05.19
25.05.19
€1.35
30.10.19
30.10.19
-98.45%
30.10.19
30.10.19
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€50.15
28.09.18
28.09.18
€3.16
22.01.19
22.01.19
-55.40%
22.01.19
22.01.19
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€47.60
26.02.18
26.02.18
€4.51
27.02.18
27.02.18
4.97%
27.02.18
27.02.18
Tetraphase Pharmaceuticals
Start price
Target price
Perf. (%)
€70.35
03.02.17
03.02.17
€6.31
06.03.17
06.03.17
62.82%
06.03.17
06.03.17